Alessandra Pavesio - Feb 14, 2022 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
SVP & Chief Science Officer
Signature
/s/ Anthony D'Adamio, Attorney-in-Fact
Stock symbol
BVS
Transactions as of
Feb 14, 2022
Transactions value $
-$5,192
Form type
4
Date filed
2/16/2022, 05:29 PM
Previous filing
Feb 15, 2022
Next filing
Apr 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BVS Class A Common Stock Sale -$5.19K -433 -0.36% $11.99 120K Feb 14, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares sold to cover taxes upon the vesting of restricted stock units on February 11, 2022 pursuant to a standing 10b5-1 instruction.